Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diabetes
MedTech
Ypsomed sells diabetes business to focus on GLP-1 self-injectors
Ypsomed plans to trade its insulin pump arm to a new Swiss medtech, TecMed, in a deal worth up to 420 million francs or about $513 million.
Conor Hale
Apr 23, 2025 6:20am
Medtronic nets FDA approval for Simplera Sync glucose tracker
Apr 21, 2025 11:00am
Dexcom wins FDA clearance for 15-day G7 CGM sensor
Apr 10, 2025 11:31am
BiomX's bacteria-killing virus reduces bone ulcers in phase 2
Mar 31, 2025 9:05am
Insulet Type 1 study shows gains in switch to auto insulin pump
Mar 20, 2025 12:12pm
Dexcom survey shows providers opt for tech over drugs in Type 2
Mar 19, 2025 12:20pm
